Literature DB >> 16374419

'Hypertension' and 'microalbuminuria': the bell tolls for thee.

J P Forman1, B M Brenner.   

Abstract

Since the terms 'hypertension' and 'microalbuminuria' were first defined, data from numerous studies have documented the continuous, rather than dichotomous, relation between blood pressure, albumin excretion, and cardiovascular disease. Lower blood pressures, down to at least 115/75 mmHg, and lower albumin excretions, below an estimated 2 mg/day, are associated with less cardiovascular risk. We hypothesize that the abundances of modern civilization superimposed on the Paleolithic genotype of humans, which has not substantially changed in the last 10 000 years, have considerably shifted the 'normal' values for blood pressure and various biochemical indices such as albuminuria still found in today's stone-aged cultures to the 'neo-normal' values observed today in the rest of the modern world. Defining a large portion of the population as 'normal' based upon these dichotomous 'neo-normal' standards is not supported by the data, and therefore seems unjustifiable. We propose that the medical community consider abandoning the terms 'hypertension' and 'microalbuminuria' in favor of 'blood pressure-associated' and 'albuminuria-associated' disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16374419     DOI: 10.1038/sj.ki.5000056

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  20 in total

1.  President's address: salt-too much of a good thing?

Authors:  Robert G Luke
Journal:  Trans Am Clin Climatol Assoc       Date:  2007

Review 2.  Integrating albuminuria and GFR in the assessment of diabetic nephropathy.

Authors:  George Jerums; Sianna Panagiotopoulos; Erosha Premaratne; Richard J MacIsaac
Journal:  Nat Rev Nephrol       Date:  2009-07       Impact factor: 28.314

Review 3.  A systematic review of glomerular hyperfiltration assessment and definition in the medical literature.

Authors:  Francois Cachat; Christophe Combescure; Michel Cauderay; Eric Girardin; Hassib Chehade
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

4.  Hypertension management: an update.

Authors:  Quang Nguyen; Joann Dominguez; Loida Nguyen; Nageshwara Gullapalli
Journal:  Am Health Drug Benefits       Date:  2010-01

5.  Predictors of incident albuminuria in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Ashish Upadhyay; James B Meigs; Caroline S Fox
Journal:  Am J Kidney Dis       Date:  2010-11       Impact factor: 8.860

6.  Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes.

Authors:  Piero Ruggenenti; Esteban Porrini; Nicola Motterlini; Annalisa Perna; Aneliya Parvanova Ilieva; Ilian Petrov Iliev; Alessandro Roberto Dodesini; Roberto Trevisan; Antonio Bossi; Giuseppe Sampietro; Enrica Capitoni; Flavio Gaspari; Nadia Rubis; Bogdan Ene-Iordache; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2012-08-30       Impact factor: 10.121

7.  Metabolic syndrome risk factors and estimated glomerular filtration rate among children and adolescents.

Authors:  Efstathios Koulouridis; Kostantinos Georgalidis; Ioulia Kostimpa; Ioannis Koulouridis; Angeliki Krokida; Despina Houliara
Journal:  Pediatr Nephrol       Date:  2009-12-10       Impact factor: 3.714

8.  Higher levels of albuminuria within the normal range predict incident hypertension.

Authors:  John P Forman; Naomi D L Fisher; Emily L Schopick; Gary C Curhan
Journal:  J Am Soc Nephrol       Date:  2008-06-25       Impact factor: 10.121

9.  Factors influencing blood pressure control in children and adolescents.

Authors:  E Koulouridis; K Georgalidis; I Kostimpa; M Kalantzi; P Ntouto; I Koulouridis; M Mandyla; A Krokida; N Boulgari
Journal:  Int Urol Nephrol       Date:  2008-04-17       Impact factor: 2.370

10.  Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.

Authors:  Salvatore De Cosmo; Nicola Motterlini; Sabrina Prudente; Fabio Pellegrini; Roberto Trevisan; Antonio Bossi; Giuseppe Remuzzi; Vincenzo Trischitta; Piero Ruggenenti
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.